Date: September 1, 2009
To: Matt Whitman
Director, Regulatory Affairs
Through: Ele Ibarra-Pratt, RN, MPH
Branch Chief, APLB
From: Lisa Stockbridge, Ph.D.
Consumer Safety Officer
Product: CERVARIX (Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant
Re: Proposed logo and Coming Soon Advertisement
The Advertising and Promotional Labeling Branch (APLB) has received GlaxoSmithKline’s (GSK) July 16, 2009, submission of a proposed logo and Coming Soon advertisement for Cervarix (Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant.
APLB has reviewed the proposed material and has no objections to its use at this time.
f you have any further questions or comments, you may contact Dr. Lisa Stockbridge, APLB Consumer Safety Officer, at 301-827-6226.